SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

12 Aug 2025 Evaluate
A slight decline in the revenue of Rs. 8102.08 millions was seen for the June 2025 quarter as against Rs. 8519.50 millions during year-ago period.The Net Profit of the company registered a slight decline of -25.91% to Rs. 694.85  millions from Rs. 937.79 millions.The Operating Profit of the company witnessed a decrease to 1567.87 millions from 1792.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 8102.08 8519.50 -4.90 8102.08 8519.50 -4.90 30301.63 37550.91 -19.31
Other Income 131.52 18.08 627.43 131.52 18.08 627.43 406.80 57.77 604.17
PBIDT 1567.87 1792.23 -12.52 1567.87 1792.23 -12.52 6054.84 8071.37 -24.98
Interest 136.73 175.17 -21.94 136.73 175.17 -21.94 627.80 719.98 -12.80
PBDT 1309.54 1617.06 -19.02 1309.54 1617.06 -19.02 5734.54 7351.39 -21.99
Depreciation 395.07 358.47 10.21 395.07 358.47 10.21 1462.30 1438.48 1.66
PBT 914.47 1258.59 -27.34 914.47 1258.59 -27.34 4272.24 5912.91 -27.75
TAX 219.62 320.80 -31.54 219.62 320.80 -31.54 1078.88 1553.73 -30.56
Deferred Tax -10.30 10.53 -197.82 -10.30 10.53 -197.82 -19.91 47.68 -141.76
PAT 694.85 937.79 -25.91 694.85 937.79 -25.91 3193.36 4359.18 -26.74
Equity 242.64 242.37 0.11 242.64 242.37 0.11 242.54 242.37 0.07
PBIDTM(%) 19.35 21.04 -8.01 19.35 21.04 -8.01 19.98 21.49 -7.04

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×